Date: Sunday, June 2, 2019
Session Time: 2:30pm-4:00pm
Presentation Time: 2:42pm-2:54pm
Location: Ballroom C
HIV+ donor to HIV+ recipient (HIV D+/R+) kidney transplantation (KT) has had success in South Africa. Expansion of this practice in the US setting of HIV resistance and heterogeneous transplant center practices merits investigation.
We performed a prospective multicenter study comparing KT outcomes between HIV+ recipients of HIV D+ and HIV-uninfected donor (D-) kidneys. Recipients had to have suppressed HIV RNA and CD4>200 cells. Immunosuppression and prophylaxis varied by center.
From 3/2016-10/2018, there were 70 kidney transplants at 12 centers: 21 D+/R+, 49 D-/R+ (of which 21 donors had false-positive HIV tests). Recipients were similar with well-controlled HIV(Table1). Survival was 100%. One graft failure (D+/R+, renal vein thrombosis), 1 HIV breakthrough (D-/R+, nonadherence) and 5 opportunistic infections occurred. Rejection was common (D-/R+, n=13, 24%; D+/R+,n=9, 43%, p=0.04) but rejection with hospitalization was rare, particularly for antithymocyte globulin(ATG) recipients(Fig1).
Under the HOPE Act, HIV D+/R+ KT has had excellent patient and graft survival with few HIV-related complications. Rejection remains a concern for recipients who did not receive ATG.
To cite this abstract in AMA style:Durand C, Huprikar S, Bowring M, Brown D, Haydel B, Desai N, Naqvi F, Friedman-Moraco R, Turgeon N, Stosor V, Charette J, Mehta S, Husson J, Gilbert A, Cooper M, Butkus-Small C, Gupta G, Mehta S, Adebiyi O, Chin-Hong P, Stock P, Massie A, Florman S, Segev D. Hope in Action: A Multicenter Prospective Study of HIV to HIV Kidney Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/hope-in-action-a-multicenter-prospective-study-of-hiv-to-hiv-kidney-transplantation/. Accessed July 24, 2021.
« Back to 2019 American Transplant Congress